Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022

SELL
$82.16 - $96.94 $26,126 - $30,826
-318 Reduced 3.24%
9,486 $805,000
Q3 2022

Oct 31, 2022

SELL
$82.16 - $96.94 $26,126 - $30,826
-318 Reduced 3.24%
9,486 $805,000
Q2 2022

Dec 01, 2022

SELL
$71.48 - $86.85 $26,018 - $31,613
-364 Reduced 3.58%
9,804 $812,000
Q2 2022

Aug 02, 2022

SELL
$71.48 - $86.85 $26,018 - $31,613
-364 Reduced 3.58%
9,804 $812,000
Q1 2022

Dec 01, 2022

BUY
$74.28 - $92.69 $19,164 - $23,914
258 Added 2.6%
10,168 $783,000
Q1 2022

May 06, 2022

BUY
$74.28 - $92.69 $19,164 - $23,914
258 Added 2.6%
10,168 $783,000
Q4 2021

Dec 01, 2022

SELL
$71.72 - $91.47 $526,137 - $671,023
-7,336 Reduced 42.54%
9,910 $875,000
Q4 2021

Feb 09, 2022

SELL
$71.72 - $91.47 $526,137 - $671,023
-7,336 Reduced 42.54%
9,910 $875,000
Q3 2021

Dec 01, 2022

SELL
$74.77 - $85.47 $65,797 - $75,213
-880 Reduced 4.85%
17,246 $1.33 Million
Q3 2021

Nov 05, 2021

SELL
$74.77 - $85.47 $65,797 - $75,213
-880 Reduced 4.85%
17,246 $1.33 Million
Q2 2021

Dec 01, 2022

BUY
$75.51 - $84.79 $133,803 - $150,247
1,772 Added 10.84%
18,126 $1.51 Million
Q2 2021

Aug 06, 2021

BUY
$75.51 - $84.79 $133,803 - $150,247
1,772 Added 10.84%
18,126 $1.51 Million
Q1 2021

Dec 01, 2022

BUY
$74.73 - $90.69 $513,768 - $623,493
6,875 Added 72.53%
16,354 $1.24 Million
Q1 2021

Apr 30, 2021

BUY
$74.73 - $90.69 $513,768 - $623,493
6,875 Added 72.53%
16,354 $1.24 Million
Q4 2020

Dec 01, 2022

BUY
$72.61 - $90.2 $152,771 - $189,780
2,104 Added 28.53%
9,479 $831,000
Q4 2020

Feb 03, 2021

BUY
$72.61 - $90.2 $152,771 - $189,780
2,104 Added 28.53%
9,479 $831,000
Q3 2020

Dec 01, 2022

SELL
$71.87 - $131.03 $140,074 - $255,377
-1,949 Reduced 20.9%
7,375 $561,000
Q3 2020

Nov 03, 2020

SELL
$71.87 - $131.03 $140,074 - $255,377
-1,949 Reduced 20.9%
7,375 $561,000
Q2 2020

Dec 01, 2022

SELL
$79.55 - $124.22 $12,887 - $20,123
-162 Reduced 1.71%
9,324 $1.15 Million
Q2 2020

Aug 06, 2020

BUY
$79.55 - $124.22 $104,130 - $162,603
1,309 Added 16.33%
9,324 $1.15 Million
Q1 2020

Apr 24, 2020

BUY
$71.37 - $96.85 $118,616 - $160,964
1,662 Added 26.16%
8,015 $677,000
Q4 2019

Feb 10, 2020

BUY
$64.27 - $86.37 $316,979 - $425,976
4,932 Added 347.08%
6,353 $537,000
Q3 2019

Nov 06, 2019

BUY
$67.4 - $85.11 $81,891 - $103,408
1,215 Added 589.81%
1,421 $96,000
Q2 2019

Aug 09, 2019

BUY
$80.35 - $93.9 $16,552 - $19,343
206 New
206 $18,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.